loader image
Monday, October 6, 2025
95.6 F
McAllen
- Advertisement -

Begley Contributes to Global Epilepsy Projects

Translate to Spanish or other 102 languages!

Charles E. Begley
Charles E. Begley

Mega Doctor News

- Advertisement -

As originally published in Mega Doctor News newsprint edition August 2018

Houston, Texas – Charles E. Begley, Ph.D., professor in the Department of Management, Policy and Community Health at UTHealth School of Public Health in Houston, has been invited to work on the Global Epilepsy Report sponsored by the World Health Organization, International League Against Epilepsy and the International Bureau for Epilepsy. Begley will serve on the editorial board for the report and as lead author of the chapter on health care response.

The purpose of the report is to raise awareness of the global burden of the disease and to identify and support possible approaches to enhance access to affordable epilepsy care and services. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally, according to the World Health Organization. Three-fourths of people with epilepsy living in low- and middle- income countries do not get the treatment they need.

- Advertisement -

“This report will provide background information and analysis leading to a global action plan for epilepsy (similar to existing plans for dementia, suicide, aging, and non-communicable diseases) with milestones, indicators, and targets to facilitate advocacy,” Begley says.

Begley also has been appointed co-chair of the International League Against Epilepsy’s Task Force on the Cost of Epilepsy. During the next four years, the task force will develop evidence-based estimates of the direct and indirect cost of epilepsy at the country, region and global levels based on reviews of the international cost literature and cost modeling.

Begley co-directs the Center for Health Services Research at UTHealth School of Public Health, which conducts research and provides technical assistance and training in the organization, financing, and outcomes of health services, systems, and policies. He has investigated the social and economic impact of epilepsy since 1994.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Unidos Contra la Diabetes to Host 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair, Nov. 5th

Unidos Contra la Diabetes (UCD) has announced that its 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support.

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.

TMA Supports Guidelines Recommending Younger Breast Cancer Screening Age

Women should begin routine annual mammography screenings at age 40, according to guidelines by the American College of Radiology and Society of Breast Imaging (ACR/SBI). Breast cancer screening guidelines vary on the initiation age for mammograms (40 versus 45 versus 50 years of age) and screening frequency (annual versus biennial).
- Advertisement -
×